By Gabriel Francisco Leonardos
August 12, 2019
Pharmaceutical IP and competition law in Brazil: 2019
Last by Gabriel Francisco Leonardos
September 3, 2021
The Covid-19 pandemic triggered the issuance of new compulsory license rules for patents in Brazil
On Sept. 2nd, 2021, Law No 14,200 was enacted to amend the Brazilian Patent & Trademark Act (BPTA) in order to change … The Covid-19 pandemic triggered the issuance of new compulsory license rules for patents in Brazil
August 27, 2021
The Brazilian FDA will no longer examine pharmaceutical patent applications
Law No. 14,195, of August 26, 2021, improves the business environment in Brazil The participation of the Brazilian agency called ANVISA … The Brazilian FDA will no longer examine pharmaceutical patent applications
June 24, 2021
Text of the Business Environment Bill is approved by the Chamber of Representatives, and it ends the prior approval for pharmaceutical patents, in addition to bringing relevant changes to trade names
The Chamber of Representatives approved this Wednesday (June 23, 2026) the text of the Bill of a new Statute for improvement of … Text of the Business Environment Bill is approved by the Chamber of Representatives, and it ends the prior approval for pharmaceutical patents, in addition to bringing relevant changes to trade names